Global Self Injection Device Market Growth 2023-2029

Global Self Injection Device Market Growth 2023-2029

The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.

An auto-injector is a medical device designed to deliver a dose of a particular drug.

LPI (LP Information)' newest research report, the “Self Injection Device Industry Forecast” looks at past sales and reviews total world Self Injection Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Self Injection Device sales for 2023 through 2029. With Self Injection Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Self Injection Device industry.

This Insight Report provides a comprehensive analysis of the global Self Injection Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Self Injection Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Self Injection Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Self Injection Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Self Injection Device.

The global Self Injection Device market size is projected to grow from US$ 8589.1 million in 2022 to US$ 11900 million in 2029; it is expected to grow at a CAGR of 11900 from 2023 to 2029.

Market competition is not intense. Novo Nordisk, Mylan, Pfizer, Sanofi, BD, Eli Lilly and Gerresheimer, etc. are the leaders of the industry, with about 60% market shares.

Europe is the largest consumption place, with a consumption market share nearly 42%. Following Europe, North America is the second largest consumption place with the consumption market share of 31%.

This report presents a comprehensive overview, market shares, and growth opportunities of Self Injection Device market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Reusable Self Injection Device

Disposable Self Injection Device

Segmentation by application

Insulin Injection

Epinephrine Injection

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Novo Nordisk

Mylan

Pfizer

Sanofi

BD

Eli Lilly

Gerresheimer

Dongbao

Ypsomed

Owen Mumford

Antares Pharma

Haselmeier

Key Questions Addressed in this Report

What is the 10-year outlook for the global Self Injection Device market?

What factors are driving Self Injection Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Self Injection Device market opportunities vary by end market size?

How does Self Injection Device break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.